RxDoctor Payments Data

Yongjin Lee, MD

Colon & Rectal Surgery · Rochester Hills, MINPI 1639528821

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 30.7% of the total. That places this record below the midpoint for colon & rectal surgery clinicians in MI, where the typical reported total is $2,435.

$1,162in general payments, 2019–2025

Across 54 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$357
  • Takeda Pharmaceuticals U.S.A., Inc.$215
  • Johnson & Johnson$124
  • Janssen Scientific Affairs, LLC$112
  • Medtronic$87
  • Axonics, Inc.$63
  • plus $204 from 9 others

What the payments were for

  • Food & beverage$1,162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,162 in reported general payments places this provider in the 35th percentile of 72 colon & rectal surgery providers in Michigan.

See all colon & rectal surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$77,489
Medicare patients
189
Services billed
429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine13$9,396
Hydrocortisone11$187
Neomycin Sulfate29$172
Oxycodone Hcl40$102
Metronidazole34$53
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$33
Gabapentin16$27
Ibuprofen11$23

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →